CRINETICS PHARMACEUTICALS IN shareholders Q3 2023

CRINETICS PHARMACEUTICALS IN's ticker is CRNX and the CUSIP is 22663K107. A total of 177 filers reported holding CRINETICS PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.5%.

CRINETICS PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
SIMPLEX TRADING, LLC 110,376$3,2820.00%
Swiss National Bank 116,400$3,461,7360.00%
NOMURA HOLDINGS INC 31,720$943,3530.00%
Hudson Bay Capital Management LP 15,000$446,1000.00%
NATIXIS ADVISORS, L.P. 25,630$7620.00%
Squarepoint Ops LLC 30,892$918,7280.00%
BARCLAYS PLC 113,282$3,3680.00%
VANGUARD GROUP INC 3,407,035$101,325,2210.00%
GTS SECURITIES LLC 45,200$1,344,2480.00%
West Tower Group, LLC 140$4,1640.00%
AMALGAMATED BANK 6,298$1870.00%
MARSHALL WACE, LLP 29,500$877,3300.00%
VICTORY CAPITAL MANAGEMENT INC 44,990$1,338,0030.00%
Mirae Asset Global Investments Co., Ltd. 36,875$1,096,6630.00%
Kestra Advisory Services, LLC 7,431$220,9980.00%
CITIGROUP INC 83,772$2,491,3790.00%
VOYA INVESTMENT MANAGEMENT LLC 52,879$1,572,6220.00%
MORGAN STANLEY 511,321$15,206,6880.00%
FRANKLIN RESOURCES INC 138,825$4,128,6550.00%
GTS SECURITIES LLC 14,200$422,3080.00%
External links

This page lists CRINETICS PHARMACEUTICALS IN's shareholders in Q3 2023. To view CRINETICS PHARMACEUTICALS IN's shareholder history, click here.